Global Clinical Risk Grouping Solutions Market to Reach US$2.3 Billion by 2030
The global market for Clinical Risk Grouping Solutions estimated at US$1.0 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 13.8% over the analysis period 2024-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Dashboard Analytics segment is estimated at 13.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$263.1 Million While China is Forecast to Grow at 18.2% CAGR
The Clinical Risk Grouping Solutions market in the U.S. is estimated at US$263.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$565.8 Million by the year 2030 trailing a CAGR of 18.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.3% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.5% CAGR.
Global Clinical Risk Grouping Solutions Market - Key Trends & Drivers Summarized
Why Are Clinical Risk Grouping Solutions Essential for Healthcare Providers?
Clinical risk grouping solutions have become vital tools for healthcare providers aiming to improve patient care and optimize financial performance by identifying and managing high-risk patient populations. These solutions analyze patient data from various sources, including Electronic Health Records (EHR), claims data, and lab results, to categorize individuals based on their clinical risk profiles. By providing a comprehensive understanding of a patient`s health risks, these solutions enable healthcare providers to implement proactive interventions, personalized care plans, and targeted resources for high-risk patients, which can help prevent complications, reduce hospital readmissions, and improve overall health outcomes. As the healthcare landscape shifts toward value-based care models, clinical risk grouping solutions are instrumental in helping providers achieve quality benchmarks and meet regulatory requirements. With accurate risk stratification, healthcare providers can allocate resources more effectively, ensuring that patients with complex health needs receive the appropriate level of care, ultimately leading to better health outcomes and cost containment.
How Are Technological Advancements Transforming Clinical Risk Grouping Solutions?
Technological advancements are significantly enhancing the accuracy and efficiency of clinical risk grouping solutions, enabling healthcare providers to gain deeper insights into patient risk profiles and manage care more effectively. Artificial Intelligence (AI) and machine learning (ML) algorithms now play a pivotal role in analyzing large datasets, identifying patterns, and predicting potential health risks with greater accuracy. These advanced algorithms can assess variables such as past medical history, genetic factors, lifestyle habits, and social determinants of health, allowing for a more holistic view of patient risk. Predictive analytics further enable healthcare providers to anticipate health issues before they escalate, facilitating early interventions. Additionally, interoperability and integration capabilities with EHR systems and other healthcare databases have improved, allowing risk grouping solutions to access comprehensive, real-time patient information across multiple care settings. This integration not only streamlines workflow but also enhances the accuracy of risk stratification, supporting timely, evidence-based decision-making. As these technologies continue to evolve, clinical risk grouping solutions are becoming more precise, predictive, and integrated, helping healthcare providers navigate the complexities of patient risk management with greater confidence.
Which Healthcare Settings Are Leveraging Clinical Risk Grouping Solutions Beyond Primary Care?
While clinical risk grouping solutions have traditionally been utilized in primary care settings to manage chronic diseases and prevent hospital readmissions, their applications are expanding into other healthcare sectors, such as specialty care, mental health, and post-acute care. In specialty care, providers use risk grouping solutions to identify patients with complex health needs, such as those undergoing cancer treatment or managing cardiovascular conditions, enabling specialists to tailor care plans to mitigate complications and enhance treatment outcomes. Mental health providers are also adopting these solutions to manage high-risk patients with conditions like severe depression or substance abuse, where proactive intervention can prevent crises and reduce the need for acute care services. In post-acute care and long-term care facilities, risk grouping solutions are invaluable for monitoring residents` health status and identifying those at risk of deterioration, helping caregivers adjust care plans accordingly. Health insurers and accountable care organizations (ACOs) are increasingly leveraging risk grouping data to design preventive programs, incentivize providers based on patient outcomes, and reduce overall healthcare costs. The adoption of clinical risk grouping solutions across these diverse settings illustrates their growing role in supporting preventive care, improving outcomes, and optimizing healthcare resources.
What’s Driving Growth in the Clinical Risk Grouping Solutions Market?
The growth in the clinical risk grouping solutions market is driven by several factors, including the shift toward value-based care, advancements in data analytics, and the need to address rising healthcare costs. The transition to value-based care models, which focus on patient outcomes and cost efficiency, has made risk grouping solutions essential, as they allow providers to identify high-risk patients and proactively manage their care. Advances in data analytics, especially AI and machine learning, have enhanced the precision and predictability of these solutions, allowing for more accurate risk stratification based on a range of clinical, behavioral, and social factors. Furthermore, interoperability with EHR systems has improved, enabling seamless access to real-time patient data across care settings and making risk grouping solutions more effective and integrated into daily workflows. The ongoing pressure to contain healthcare costs has also driven the adoption of these solutions, as they help prevent expensive hospitalizations and emergency room visits by enabling early intervention for high-risk patients. Additionally, healthcare organizations are increasingly investing in clinical risk grouping solutions to meet regulatory standards, improve care quality, and enhance patient satisfaction. These factors collectively indicate a promising growth trajectory for the clinical risk grouping solutions market, driven by technological advancements and the ongoing focus on cost-effective, high-quality patient care.
SCOPE OF STUDY:The report analyzes the Clinical Risk Grouping Solutions market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:Product (Scorecard & Visualization Tools, Dashboard Analytics, Risk Reporting); Deployment (Private Cloud, Public Cloud, Hybrid Cloud); End-Use (Hospitals, Ambulatory Care Centers, Other End-Uses)
Geographic Regions/Countries:World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 34 Featured) - - 3M Company
- 4S DAWN Clinical Software
- 4S Information Systems Ltd.
- Cerner Corporation
- Change Healthcare
- Conduent Incorporated
- Cotiviti, Inc.
- Dynamic Healthcare Systems, Inc.
- Episource, Med-IQ, Inc.
- Evolent Health
- HBI Solutions, Inc.
- Health Catalyst Inc.
- Indegene
- Intalere
- Johns Hopkins University
- Lightbeam Health Solutions, LLC
- Milliman, Inc.
- Nuance Communications
- Optum Inc. (A Subsidiary of Unitedhealth Group Inc.)
- Perahealth, Inc.
- The Johns Hopkins University
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs CBob geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.
We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.
As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.
To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!
APRIL 2025: NEGOTIATION PHASE
Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.
JULY 2025 FINAL TARIFF RESET
Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.
Reciprocal and Bilateral Trade & Tariff Impact Analyses:
USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.
Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.